Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991

Leukemia. 1992:6 Suppl 2:78-80.

Authors

M J Keating¹, E Estey, H Kantarjian, W Plunkett, S O'Brien, C Koller, M Beran, E J Freireich

Affiliation

¹ University of Texas M.D. Anderson Cancer Center, Houston.

PMID: 1578950

No abstract available

Publication types

Review

MeSH terms

Amsacrine / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cytarabine / administration & dosage
Daunorubicin / administration & dosage
Drug Administration Schedule
Humans
Idarubicin / administration & dosage
Leukemia, Myeloid, Acute / drug therapy*
Myelodysplastic Syndromes / drug therapy*
Vidarabine / administration & dosage
Vidarabine / analogs & derivatives

Substances

Amsacrine
Cytarabine
Vidarabine
fludarabine
Idarubicin
Daunorubicin